{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T23:56:49Z","timestamp":1783382209769,"version":"3.54.6"},"reference-count":57,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,6,4]],"date-time":"2027-06-04T00:00:00Z","timestamp":1812067200000},"content-version":"am","delay-in-days":307,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100006492","name":"National Institute of Allergy and Infectious Diseases Division of Intramural Research","doi-asserted-by":"publisher","award":["R37AI34495"],"award-info":[{"award-number":["R37AI34495"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017540","name":"National Heart Lung and Blood Institute Division of Intramural Research","doi-asserted-by":"publisher","award":["2T32HL007062"],"award-info":[{"award-number":["2T32HL007062"]}],"id":[{"id":"10.13039\/100017540","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017540","name":"National Heart Lung and Blood Institute Division of Intramural Research","doi-asserted-by":"publisher","award":["R01HL11879"],"award-info":[{"award-number":["R01HL11879"]}],"id":[{"id":"10.13039\/100017540","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017540","name":"National Heart Lung and Blood Institute Division of Intramural Research","doi-asserted-by":"publisher","award":["P01HL158505"],"award-info":[{"award-number":["P01HL158505"]}],"id":[{"id":"10.13039\/100017540","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["324392634"],"award-info":[{"award-number":["324392634"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["B07"],"award-info":[{"award-number":["B07"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["CRC221"],"award-info":[{"award-number":["CRC221"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010400","name":"Children's Mercy Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010400","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jcyt.2026.102879","type":"journal-article","created":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T23:22:12Z","timestamp":1775690532000},"page":"102879","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["A novel method for efficient murine regulatory T-cell expansion and retroviral transduction"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9998-5123","authenticated-orcid":false,"given":"Cameron","family":"McDonald-Hyman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-2667-9814","authenticated-orcid":false,"given":"Pooja Shree Marri","family":"Baskar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-1477-1225","authenticated-orcid":false,"given":"Yiyun","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valencia","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tirza","family":"Brandl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Edinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce R.","family":"Blazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcyt.2026.102879_bib0001","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.immuni.2013.03.002","article-title":"Development and maintenance of regulatory T cells","volume":"38","author":"Ohkura","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.jcyt.2026.102879_bib0002","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.cell.2008.05.009","article-title":"Regulatory T cells and immune tolerance","volume":"133","author":"Sakaguchi","year":"2008","journal-title":"Cell."},{"key":"10.1016\/j.jcyt.2026.102879_bib0003","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1146\/annurev-immunol-100219-020937","article-title":"Regulatory T cell development","volume":"38","author":"Savage","year":"2020","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jcyt.2026.102879_bib0004","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41573-024-01089-x","article-title":"Harnessing the biology of regulatory T cells to treat disease","volume":"24","author":"Wardell","year":"2025","journal-title":"Nature Reviews Drug Discovery"},{"key":"10.1016\/j.jcyt.2026.102879_bib0005","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/s41392-025-02326-4","article-title":"Regulatory T cells in homeostasis and disease: molecular mechanisms and therapeutic potential","volume":"10","author":"Wang","year":"2025","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.jcyt.2026.102879_bib0006","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/s41577-019-0232-6","article-title":"Treg cell-based therapies: challenges and perspectives","volume":"20","author":"Raffin","year":"2020","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jcyt.2026.102879_bib0007","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1016\/j.jaci.2018.10.015","article-title":"Regulatory T-cell therapy for autoimmune and autoinflammatory diseases: the next frontier","volume":"142","author":"Esensten","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jcyt.2026.102879_bib0008","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1038\/nm915","article-title":"CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation","volume":"9","author":"Edinger","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.jcyt.2026.102879_bib0009","doi-asserted-by":"crossref","first-page":"3493","DOI":"10.1182\/blood.V99.10.3493","article-title":"The infusion of ex vivo activated and expanded CD4+CD25+ immune regulatory cells inhibits graft-versus-host disease lethality","volume":"99","author":"Taylor","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2026.102879_bib0010","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1084\/jem.193.11.1311","article-title":"Cd4+Cd25+ immune regulatory cells are required for induction of tolerance to alloantigen via costimulatory blockade","volume":"193","author":"Taylor","year":"2001","journal-title":"J Exp Med"},{"key":"10.1016\/j.jcyt.2026.102879_bib0011","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1126\/scitranslmed.3001809","article-title":"Massive ex vivo expansion of human natural regulatory T cells (Tregs) with minimal loss of in vivo functional activity","volume":"3","author":"Hippen","year":"2011","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jcyt.2026.102879_bib0012","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1111\/j.1600-6143.2011.03558.x","article-title":"Generation and large-scale expansion of human inducible regulatory T cells that suppress graft-versus-host disease","volume":"11","author":"Hippen","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jcyt.2026.102879_bib0013","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaa6853","article-title":"Advances and challenges in immunotherapy for solid organ and hematopoietic stem cell transplantation","volume":"7","author":"McDonald-Hyman","year":"2015","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jcyt.2026.102879_bib0014","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nrrheum.2014.105","article-title":"TREG-cell therapies for autoimmune rheumatic diseases","volume":"10","author":"Miyara","year":"2014","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.jcyt.2026.102879_bib0015","doi-asserted-by":"crossref","DOI":"10.1172\/JCI182480","article-title":"Acetyl-CoA carboxylase-1 inhibition increases regulatory T-cell metabolism and graft-vs-host disease treatment efficacy via mitochondrial fusion","volume":"135","author":"McDonald-Hyman","year":"2025","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jcyt.2026.102879_bib0016","doi-asserted-by":"crossref","first-page":"4604","DOI":"10.1172\/JCI95713","article-title":"The vimentin intermediate filament network restrains regulatory T cell suppression of graft-versus-host disease","volume":"128","author":"McDonald-Hyman","year":"2018","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jcyt.2026.102879_bib0017","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.ajt.2023.01.030","article-title":"Enforced gut homing of murine regulatory T cells reduces early graft-versus-host disease severity","volume":"23","author":"Larson","year":"2023","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jcyt.2026.102879_bib0018","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/ajt.12509","article-title":"Attenuation of donor-reactive T cells allows effective control of allograft rejection using regulatory T cell therapy","volume":"14","author":"Lee","year":"2014","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jcyt.2026.102879_bib0019","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1016\/j.transproceed.2013.01.073","article-title":"Donor-specific regulatory T cells generated on donor B cells are superior to CD4+CD25high cells in controlling alloimmune responses in humanized mice","volume":"45","author":"Noyan","year":"2013","journal-title":"Transplant Proc"},{"key":"10.1016\/j.jcyt.2026.102879_bib0020","doi-asserted-by":"crossref","first-page":"5671","DOI":"10.1182\/blood-2011-02-337097","article-title":"Ex vivo expansion of human Tregs specific for alloantigens presented directly or indirectly","volume":"118","author":"Veerapathran","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2026.102879_bib0021","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3002076","article-title":"Human regulatory T cells with alloantigen specificity are more potent inhibitors of alloimmune skin graft damage than polyclonal regulatory T cells","volume":"3","author":"Sagoo","year":"2011","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jcyt.2026.102879_bib0022","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1056\/NEJMoa1709919","article-title":"Long-Term Follow-up of CD19 CAR therapy in acute lymphoblastic leukemia","volume":"378","author":"Park","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcyt.2026.102879_bib0023","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1056\/NEJMoa1708566","article-title":"Chimeric antigen receptor T cells in refractory B-cell lymphomas","volume":"377","author":"Schuster","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcyt.2026.102879_bib0024","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1056\/NEJMc2509522","article-title":"In vivo CD19 CAR T-cell therapy for refractory systemic lupus erythematosus","volume":"393","author":"Wang","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcyt.2026.102879_bib0025","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1056\/NEJMoa2308917","article-title":"CD19 CAR T-cell therapy in autoimmune disease\u2014a case series with follow-up","volume":"390","author":"M\u00fcller","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcyt.2026.102879_bib0026","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.934343","article-title":"Regulatory CAR-T cells in autoimmune diseases: progress and current challenges","volume":"13","author":"Riet","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jcyt.2026.102879_bib0027","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellimm.2020.104220","article-title":"Building a CAR-Treg: going from the basic to the luxury model","volume":"358","author":"Rosado-S\u00e1nchez","year":"2020","journal-title":"Cell Immunol"},{"key":"10.1016\/j.jcyt.2026.102879_bib0028","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1172\/JCI86827","article-title":"Driving allotolerance: CAR-expressing Tregs for tolerance induction in organ and stem cell transplantation","volume":"126","author":"Edinger","year":"2016","journal-title":"J Clin Invest"},{"issue":"7","key":"10.1016\/j.jcyt.2026.102879_bib0029","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.188624","article-title":"CAR Treg synergy with anti-CD154 promotes infectious tolerance and dictates allogeneic heart transplant acceptance","volume":"10","author":"Durgam","year":"2025","journal-title":"JCI Insight"},{"issue":"19","key":"10.1016\/j.jcyt.2026.102879_bib0030","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.167215","article-title":"Tregs integrate native and CAR-mediated costimulatory signals for control of allograft rejection","volume":"8","author":"Rosado-S\u00e1nchez","year":"2023","journal-title":"JCI Insight"},{"key":"10.1016\/j.jcyt.2026.102879_bib0031","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2022.102961","article-title":"Flagellin-specific human CAR Tregs for immune regulation in IBD","volume":"134","author":"Boardman","year":"2023","journal-title":"J Autoimmun"},{"issue":"17","key":"10.1016\/j.jcyt.2026.102879_bib0032","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.160674","article-title":"Murine CAR19 Tregs suppress acute graft-versus-host disease and maintain graft-versus-tumor responses","volume":"7","author":"Bolivar-Wagers","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.jcyt.2026.102879_bib0033","article-title":"Insulin B peptide-MHC class II-specific chimeric antigen receptor-Tregs prevent autoimmune diabetes","author":"Spanier","year":"2023","journal-title":"bioRxiv"},{"key":"10.1016\/j.jcyt.2026.102879_bib0034","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.smim.2006.01.004","article-title":"Antigen-specific regulatory T cells\u2014ex vivo expansion and therapeutic potential","volume":"18","author":"Masteller","year":"2006","journal-title":"Semin Immunol"},{"key":"10.1016\/j.jcyt.2026.102879_bib0035","doi-asserted-by":"crossref","DOI":"10.1016\/j.jim.2020.112931","article-title":"A method for expansion and retroviral transduction of mouse regulatory T cells","volume":"488","author":"Wu","year":"2021","journal-title":"J Immunol Methods"},{"key":"10.1016\/j.jcyt.2026.102879_bib0036","doi-asserted-by":"crossref","DOI":"10.1038\/mtm.2014.30","article-title":"Ex vivo expanded autologous polyclonal regulatory T cells suppress inhibitor formation in hemophilia","volume":"1","author":"Sarkar","year":"2014","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10.1016\/j.jcyt.2026.102879_bib0037","doi-asserted-by":"crossref","first-page":"858","DOI":"10.4049\/jimmunol.180.2.858","article-title":"In vitro expansion improves in vivo regulation by CD4+ CD25+ regulatory T cells","volume":"180","author":"Chai","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.jcyt.2026.102879_bib0038","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1084\/jem.20042398","article-title":"Single cell analysis shows decreasing FoxP3 and TGFbeta1 coexpressing CD4+CD25+ regulatory T cells during autoimmune diabetes","volume":"201","author":"Pop","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/j.jcyt.2026.102879_bib0039","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.4049\/jimmunol.169.5.2461","article-title":"The subpopulation of CD4+CD25+ splenocytes that delays adoptive transfer of diabetes expresses L-selectin and high levels of CCR7","volume":"169","author":"Szanya","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.jcyt.2026.102879_bib0040","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1016\/j.ymthe.2024.05.006","article-title":"GLUT1 overexpression enhances CAR T cell metabolic fitness and anti-tumor efficacy","volume":"32","author":"Shi","year":"2024","journal-title":"Mol Ther"},{"key":"10.1016\/j.jcyt.2026.102879_bib0041","article-title":"Chimeric antigen receptor-induced antigen loss protects CD5.CART cells from fratricide without compromising on-target cytotoxicity","volume":"5","author":"Ma","year":"2024","journal-title":"Cell Rep Med"},{"key":"10.1016\/j.jcyt.2026.102879_bib0042","article-title":"Preclinical evaluation of CD70-specific CAR T cells targeting acute myeloid leukemia","volume":"14","author":"Wu","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.jcyt.2026.102879_bib0043","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1182\/blood.2021015020","article-title":"Engineering naturally occurring CD7-T cells for the immunotherapy of hematological malignancies","volume":"140","author":"Freiwan","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2026.102879_bib0044","doi-asserted-by":"crossref","first-page":"4479","DOI":"10.1172\/JCI69589","article-title":"Inhibiting glycolytic metabolism enhances CD8+ T cell memory and antitumor function","volume":"123","author":"Sukumar","year":"2013","journal-title":"J Clin Invest"},{"issue":"12","key":"10.1016\/j.jcyt.2026.102879_bib0045","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-005934","article-title":"Human CD19-specific switchable CAR T-cells are efficacious as constitutively active CAR T-cells but cause less morbidity in a mouse model of human CD19(+) malignancy","volume":"10","author":"Pennell","year":"2022","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.jcyt.2026.102879_bib0046","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/j.ymthe.2018.04.006","article-title":"Human CD19-targeted mouse T cells induce B cell aplasia and toxicity in human CD19 transgenic mice","volume":"26","author":"Pennell","year":"2018","journal-title":"Mol Ther"},{"key":"10.1016\/j.jcyt.2026.102879_bib0047","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/s41375-019-0625-3","article-title":"Efficient treatment of murine acute GvHD by in vitro expanded donor regulatory T cells","volume":"34","author":"Riegel","year":"2020","journal-title":"Leukemia"},{"key":"10.1016\/j.jcyt.2026.102879_bib0048","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1182\/blood.2024025884","article-title":"Targeting cell surface VISTA expression on allospecific na\u00efve T cells promotes tolerance","volume":"145","author":"Koehn","year":"2025","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2026.102879_bib0049","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1182\/blood.V88.8.3230.bloodjournal8883230","article-title":"An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation: I. The roles of minor H antigens and endotoxin","volume":"88","author":"Cooke","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2026.102879_bib0050","doi-asserted-by":"crossref","first-page":"3804","DOI":"10.1182\/blood-2004-05-1850","article-title":"L-Selectinhi but not the L-selectinlo CD4+25+ T-regulatory cells are potent inhibitors of GVHD and BM graft rejection","volume":"104","author":"Taylor","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2026.102879_bib0051","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1046\/j.1600-6143.2003.00293.x","article-title":"CD4+ CD25+ CD62+ T-regulatory cell subset has optimal suppressive and proliferative potential","volume":"4","author":"Fu","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jcyt.2026.102879_bib0052","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1182\/blood-2004-05-2044","article-title":"Only the CD62L+ subpopulation of CD4+CD25+ regulatory T cells protects from lethal acute GVHD","volume":"105","author":"Ermann","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2026.102879_bib0053","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/978-1-4939-2809-5_8","article-title":"Retroviral transduction of T cells and T cell precursors","volume":"1323","author":"Simmons","year":"2016","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.jcyt.2026.102879_bib0054","article-title":"Optimized conditions for gene transduction into primary immune cells using viral vectors","volume":"13","author":"Kim","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.jcyt.2026.102879_bib0055","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1089\/152581603321210208","article-title":"Efficient transduction of murine primary T cells requires a combination of high viral titer, preferred tropism, and proper timing of transduction","volume":"12","author":"Zhang","year":"2003","journal-title":"J Hematother Stem Cell Res"},{"key":"10.1016\/j.jcyt.2026.102879_bib0056","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0022-1759(03)00010-3","article-title":"T cell stimulation and expansion using anti-CD3\/CD28 beads","volume":"275","author":"Trickett","year":"2003","journal-title":"J Immunological Methods"},{"key":"10.1016\/j.jcyt.2026.102879_bib0057","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2021.100719","article-title":"An optimized protocol for the retroviral transduction of mouse CD4 T cells","volume":"2","author":"Eremenko","year":"2021","journal-title":"STAR Protocols"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324926008406?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324926008406?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T11:26:37Z","timestamp":1783337197000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324926008406"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":57,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S1465324926008406"],"URL":"https:\/\/doi.org\/10.1016\/j.jcyt.2026.102879","relation":{},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel method for efficient murine regulatory T-cell expansion and retroviral transduction","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcyt.2026.102879","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 International Society for Cellular Therapy. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"102879"}}